| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 1,022 | 57.9% | 0.23 | 1,198 | 66.3% |
| AL(R) | 697 | 39.5% | -0.26 | 582 | 32.2% |
| CentralBrain-unspecified | 45 | 2.5% | -0.74 | 27 | 1.5% |
| LAL(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ORN_DL3 | % In | CV |
|---|---|---|---|---|---|
| ORN_DL3 | 102 | ACh | 20.8 | 56.6% | 0.7 |
| lLN2T_b (L) | 2 | ACh | 2.8 | 7.6% | 0.1 |
| lLN2F_a (L) | 1 | unc | 1.4 | 3.9% | 0.0 |
| ALIN5 (L) | 1 | GABA | 1.3 | 3.4% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1.3 | 3.4% | 0.0 |
| lLN2T_b (R) | 1 | ACh | 0.9 | 2.5% | 0.0 |
| lLN2T_e (R) | 2 | ACh | 0.9 | 2.5% | 0.4 |
| lLN2P_b (R) | 2 | GABA | 0.9 | 2.4% | 0.1 |
| lLN2T_e (L) | 2 | ACh | 0.8 | 2.3% | 0.8 |
| lLN2P_b (L) | 3 | GABA | 0.8 | 2.1% | 0.5 |
| v2LN36 (R) | 1 | Glu | 0.7 | 2.0% | 0.0 |
| DL3_lPN (L) | 5 | ACh | 0.7 | 1.9% | 0.8 |
| lLN2F_a (R) | 2 | unc | 0.5 | 1.5% | 0.5 |
| ORN_DA1 | 16 | ACh | 0.5 | 1.5% | 0.2 |
| ORN_DL4 | 8 | ACh | 0.5 | 1.3% | 0.6 |
| lLN2P_a (R) | 1 | GABA | 0.3 | 0.8% | 0.0 |
| lLN1_bc (R) | 4 | ACh | 0.2 | 0.5% | 0.6 |
| lLN2F_b (R) | 2 | GABA | 0.2 | 0.4% | 0.6 |
| il3LN6 (R) | 1 | GABA | 0.2 | 0.4% | 0.0 |
| DL3_lPN (R) | 3 | ACh | 0.2 | 0.4% | 0.3 |
| v2LN36 (L) | 1 | Glu | 0.2 | 0.4% | 0.0 |
| lLN2T_c (R) | 1 | ACh | 0.1 | 0.4% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 0.1 | 0.4% | 0.0 |
| lLN2X04 (L) | 1 | ACh | 0.1 | 0.3% | 0.0 |
| ORN_DA2 | 1 | ACh | 0.1 | 0.2% | 0.0 |
| lLN1_bc (L) | 1 | ACh | 0.1 | 0.2% | 0.0 |
| lLN2X04 (R) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DA4l | 1 | ACh | 0.0 | 0.1% | 0.0 |
| lLN2T_c (L) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| AL-MBDL1 (R) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| DA1_lPN (R) | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_D | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DA3 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| downstream partner | # | NT | conns ORN_DL3 | % Out | CV |
|---|---|---|---|---|---|
| DL3_lPN (L) | 5 | ACh | 46.7 | 28.6% | 0.5 |
| DL3_lPN (R) | 6 | ACh | 32.5 | 19.9% | 0.1 |
| ORN_DL3 | 101 | ACh | 22.7 | 13.9% | 0.7 |
| lLN2T_b (L) | 2 | ACh | 7.7 | 4.7% | 0.2 |
| v2LN36 (R) | 1 | Glu | 7.7 | 4.7% | 0.0 |
| lLN2P_b (L) | 3 | GABA | 7.1 | 4.3% | 0.5 |
| lLN2F_a (L) | 1 | unc | 4.9 | 3.0% | 0.0 |
| v2LN30 (L) | 1 | unc | 4.5 | 2.7% | 0.0 |
| v2LN36 (L) | 1 | Glu | 3.8 | 2.3% | 0.0 |
| lLN2P_a (R) | 1 | GABA | 3.2 | 2.0% | 0.0 |
| lLN2P_a (L) | 2 | GABA | 3.0 | 1.8% | 0.6 |
| il3LN6 (R) | 1 | GABA | 2.6 | 1.6% | 0.0 |
| lLN2T_c (L) | 2 | ACh | 2.5 | 1.5% | 0.6 |
| lLN2P_b (R) | 4 | GABA | 2.1 | 1.3% | 1.0 |
| lLN2T_b (R) | 1 | ACh | 1.5 | 0.9% | 0.0 |
| ALIN7 (R) | 1 | GABA | 1.2 | 0.8% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 1.1 | 0.7% | 0.0 |
| lLN2T_e (L) | 2 | ACh | 1.0 | 0.6% | 0.6 |
| lLN2T_a (L) | 2 | ACh | 0.8 | 0.5% | 0.6 |
| ORN_DA1 | 18 | ACh | 0.8 | 0.5% | 0.5 |
| lLN2T_c (R) | 1 | ACh | 0.7 | 0.4% | 0.0 |
| lLN2F_a (R) | 2 | unc | 0.7 | 0.4% | 0.3 |
| lLN2T_e (R) | 2 | ACh | 0.6 | 0.4% | 0.2 |
| lLN2X04 (L) | 1 | ACh | 0.5 | 0.3% | 0.0 |
| ORN_DL4 | 9 | ACh | 0.5 | 0.3% | 0.7 |
| lLN2P_c (L) | 1 | GABA | 0.4 | 0.3% | 0.0 |
| v2LN30 (R) | 1 | unc | 0.3 | 0.2% | 0.0 |
| ALIN5 (R) | 1 | GABA | 0.3 | 0.2% | 0.0 |
| lLN1_bc (R) | 3 | ACh | 0.2 | 0.1% | 0.5 |
| CB2845 (R) | 2 | unc | 0.2 | 0.1% | 0.7 |
| lLN2X04 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| lLN2T_a (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| lLN2P_c (R) | 1 | GABA | 0.2 | 0.1% | 0.0 |
| lLN2F_b (R) | 2 | GABA | 0.2 | 0.1% | 0.6 |
| ALIN7 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| ALIN5 (L) | 1 | GABA | 0.1 | 0.1% | 0.0 |
| CB3679 (L) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_DC4 | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN3A (L) | 1 | unc | 0.1 | 0.0% | 0.0 |
| M_ilPNm90 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_lvPNm24 (R) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DA3 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CB2845 (L) | 1 | unc | 0.0 | 0.0% | 0.0 |
| M_l2PNm16 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_vPNml50 (R) | 1 | GABA | 0.0 | 0.0% | 0.0 |
| M_lvPNm24 (L) | 1 | ACh | 0.0 | 0.0% | 0.0 |
| AL-MBDL1 (R) | 1 | ACh | 0.0 | 0.0% | 0.0 |
